Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul;19(7):56.
doi: 10.1007/s11936-017-0555-1.

Advanced Neuroimaging of Cerebral Small Vessel Disease

Affiliations
Review

Advanced Neuroimaging of Cerebral Small Vessel Disease

Gordon W Blair et al. Curr Treat Options Cardiovasc Med. 2017 Jul.

Abstract

Cerebral small vessel disease (SVD) is characterised by damage to deep grey and white matter structures of the brain and is responsible for a diverse range of clinical problems that include stroke and dementia. In this review, we describe advances in neuroimaging published since January 2015, mainly with magnetic resonance imaging (MRI), that, in general, are improving quantification, observation and investigation of SVD focussing on three areas: quantifying the total SVD burden, imaging brain microstructural integrity and imaging vascular malfunction. Methods to capture 'whole brain SVD burden' across the spectrum of SVD imaging changes will be useful for patient stratification in clinical trials, an approach that we are already testing. More sophisticated imaging measures of SVD microstructural damage are allowing the disease to be studied at earlier stages, will help identify specific factors that are important in development of overt SVD imaging features and in understanding why specific clinical consequences may occur. Imaging vascular function will help establish the precise blood vessel and blood flow alterations at early disease stages and, together with microstructural integrity measures, may provide important surrogate endpoints in clinical trials testing new interventions. Better knowledge of SVD pathophysiology will help identify new treatment targets, improve patient stratification and may in future increase efficiency of clinical trials through smaller sample sizes or shorter follow-up periods. However, most of these methods are not yet sufficiently mature to use with confidence in clinical trials, although rapid advances in the field suggest that reliable quantification of SVD lesion burden, tissue microstructural integrity and vascular dysfunction are imminent.

Keywords: Cerebrovascular disease; Lacunes; Magnetic resonance imaging; Microbleeds; Small vessel disease; White matter hyperintensities.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Gordon W. Blair reports grants from Alzheimer’s Society and European Union Horizon 2020 Program.

Maria Valdez Hernandez reports grants from Medical Research Council, Innovate UK, Wellcome Trust, Chief Scientist Office, Row Fogo Charitable Trust, Engineering and Physical Science Research Council, Scottish Funding Council, and Alzheimer’s Society.

Michael J. Thrippleton declares no potential conflicts of interest.

Fergus N. Doubal reports grants from Stroke Association, Engineering and Physical Science Research Council, Alzheimer’s Society and Medical Research Council.

Joanna M. Wardlaw reports grants from Wellcome Trust, Medical Research Council, Engineering and Physical Science Research Council, Chief Scientist Office, Scottish Funding Council, Innovate UK and Alzheimer’s Society.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Figures

Fig. 1
Fig. 1
Graphical representation of the proportions of papers published since January 2015 until March 2017 on computational methods to assess small vessel disease imaging markers and sample size involved. Legend: PVS perivascular spaces, WMH white matter hyperintensities, BMB brain microbleeds, ROIs regions of interest.

References

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483–497. doi: 10.1016/S1474-4422(13)70060-7. - DOI - PMC - PubMed
    1. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration: a united approach. Lancet Neurol. 2013;12(8):822–838. doi: 10.1016/S1474-4422(13)70124-8. - DOI - PMC - PubMed
    1. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666. doi: 10.1136/bmj.c3666. - DOI - PMC - PubMed
    1. Harteveld AA, van der Kolk AG, Zwanenburg JJ, Luijten PR, Hendrikse J. 7-T MRI in cerebrovascular diseases: challenges to overcome and initial results. Top Magn Reson Imaging. 2016;25(2):89–100. - PubMed
    1. Khan U, Porteous L, Hassan A, Markus HS. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry. 2007;78(7):702–706. doi: 10.1136/jnnp.2006.103549. - DOI - PMC - PubMed

LinkOut - more resources